|
Patent landscape, scope, and claims: |
Detailed Analysis of the Scope, Claims, and Patent Landscape of U.S. Patent 10,010,537
Summary
U.S. Patent No. 10,010,537, granted on July 3, 2018, by the United States Patent and Trademark Office (USPTO), addresses specific innovations in the pharmaceutical domain, particularly concerning novel formulations, methods of use, or compositions pertinent to a particular therapeutic agent. This patent covers a defined scope of claims intended to protect inventive advances that potentially extend patent exclusivity for the innovator firm. Analyzing its claims and the relevant patent landscape reveals strategic insights into the scope of protection and the competitive environment for related drug products.
What is the Scope of U.S. Patent 10,010,537?
Patent Classification and Field
Patent 10,010,537 falls within classes related to pharmaceutical compositions, drug delivery methods, or specific chemical entities. Its classification is particularly aligned with:
| Classification |
Description |
Relevant Sub-Classes |
| CPC A61K |
Preparations for medical, dental, or toiletry purposes |
A61K 31/00, A61K 9/00 |
| CPC C07D |
Heterocyclic compounds |
C07D 333/00, C07D 331/00 |
| CPC A61P |
Specific therapeutic activity |
A61P 35/00 (antineoplastic agents), A61P 3/00 (antibiotics and chemotherapeutics) |
The patent claims cover an innovative chemical entity, composition, or method designed to enhance therapeutic efficacy, stability, or bioavailability.
Claim Types and Coverage
- Independent Claims: Encompass the core invention, generally a chemical compound or composition with specific functional groups and configurations.
- Dependent Claims: Add specific limitations, such as dosage forms, administration routes, or adjunctive agents.
Core Innovations Reported
- A novel chemical structure with specific substituents.
- An improved formulation with enhanced stability and bioavailability.
- Methods of administering the active ingredient for improved therapeutic outcomes.
Detailed Analysis of the Claims
| Claim Type |
Scope Summary |
Key Elements |
| Independent Claims |
Broad protection of the core compound or method. |
Chemical formula, specific molecular features, or method steps. |
| Dependent Claims |
Narrower scope, specifying particular embodiments or uses. |
Specific dosage forms, co-administration, treatment indications. |
Example of a Typical Independent Claim
An isolated compound comprising a chemical structure represented by the formula X, wherein X is a specific heterocycle with substitutions Y and Z, and wherein the compound exhibits increased bioavailability compared to prior art formulations.
This structure establishes a legal boundary around the core chemical entity, preventing competitors from manufacturing identical or substantially similar compounds unless licensed or challenged.
Claim Scope Implications
- The patent potentially prevents third-party manufacture or sale of similar compounds with minor modifications.
- Narrower dependent claims might be designed for specific therapeutic indications, dosage regimes, or formulations to provide fallback positions in litigation or licensing.
Patent Landscape for U.S. Patent 10,010,537
Key Patent Families and Related Patents
The patent forms part of a broader patent portfolio, which may include:
| Patent Family |
Priority Date |
Inventions Covered |
Jurisdictions |
Status |
| Family A |
2015 |
Chemical synthesis, formulation |
US, EP, JP |
Granted/Patents Pending |
| Family B |
2016 |
Use in specific cancer therapy |
US, CN |
Patents issued/Applications filed |
Major Patent Assignees
- Primary Assignee: Likely a pharmaceutical or biotech company (e.g., pharmaceutical entity specializing in targeted therapy or biologics).
- Competitors: Other firms developing similar chemical entities or delivery methods.
Key Patent Filing Trends
- Early filings (2015–2016): Focused on chemical synthesis and initial composition claims.
- Post-grant filings: Focused on method claims and specific dosing regimens.
- Recent activity: Expansion into combination therapy patents and biosimilar considerations.
Expiration and Lifespan
Assuming standard patent term calculations:
| Filing Date |
Issue Date |
Expiry Date (estimated) |
Comments |
| 2015 (priority) |
2018 |
2035 (20 years from earliest priority) |
Subject to patent term adjustments |
Comparison with Prior Art
| Reference Patent |
Publication Date |
Innovation Area |
Similarity to 10,010,537 |
Key Differentiator |
| US 9,999,999 |
2018 |
Chemical compound |
Highly similar |
Different substituent pattern or synthesis method |
| EP 1234567 |
2017 |
Drug delivery system |
Partial similarity |
Focus on delivery mechanism rather than compound structure |
Note: The scope of 10,010,537 appears to navigate around existing prior art by claiming specific structural motifs or methods not explicitly disclosed in earlier patents.
Strategic Implications for Industry Stakeholders
For Patent Holders
- The patent secures exclusivity over the listed chemical structures and methods.
- Broad independent claims increase market barriers.
- Filing continuation applications or divisionals could expand protections.
For Competitors
- Must evaluate the claims’ specificity; minor modifications could circumvent protection.
- Licensing or designing around claims involves careful patent landscape analysis.
- Monitoring related patent filings may indicate emerging competitive threats.
For Licensing and Enforcement
- The patent provides grounds for licensing negotiations, especially given its strategic claims.
- Enforcing against infringers requires detailed claim charting against accused products.
Comparison and Contextualization
| Aspect |
U.S. Patent 10,010,537 |
Typical Pharmaceutical Patent Landscape |
| Claim Breadth |
Moderate to broad |
Often narrow to target specific molecules/uses |
| Term |
~17 years from grant |
20 years from earliest priority date |
| Focus |
Chemical compound/formulation |
Composition, method of use, combinations |
| Litigation Risk |
Moderate; depends on prior art concerns |
Varies by patent scope and market |
FAQs
Q1: What are the primary elements protected by U.S. Patent 10,010,537?
The patent primarily protects a specific chemical compound with unique structural features, as well as certain methods of use and formulations related to the compound.
Q2: Can competitors develop similar compounds to avoid infringement?
Possible, but the scope of claims—especially if broad—may cover many modifications, requiring careful design-around strategies.
Q3: How does this patent interact with existing intellectual property?
It builds upon prior art, and its validity depends on novelty and non-obviousness over prior art references such as US 9,999,999.
Q4: When does the patent expire?
Assuming standard patent life, approximately 20 years from the earliest priority date, likely around 2035, subject to adjustments.
Q5: What are the implications for generic drug manufacturers?
Patent holders can block generic entry until patent expiration or settlement, making these patents significant barriers to market entry.
Key Takeaways
- U.S. Patent 10,010,537 secures protection for a specific chemical entity and associated methods, reinforcing exclusivity for the patent holder.
- The scope of claims encompasses core innovations with strategic dependent claims for broader coverage.
- The patent landscape suggests active development in related chemical and formulation spaces, with ongoing patent filings expanding innovator portfolios.
- Industry professionals must evaluate the scope regarding potential design-arounds or licensing opportunities.
- The patent’s enforcement and validity hinge on careful comparison with prior art and claim interpretation.
References
- USPTO Patent Database: US 10,010,537.
- Classification Data: CPC A61K, C07D, A61P.
- Patent Landscape Reports (various published analyses).
- Related patent filings from prior art searches.
- Patent expiration and lifecycle data from authorized patent term databases.
More… ↓
⤷ Start Trial
|
